Skip to content
Abierto
Menu

Combined synopsis and solicitation, total small business set-aside

Ophthalmic Adaptive Optics (AO) Retinal Imaging System

RFQ-FDA-133666

Food and Drug Administration, FDA Office of Acq Grant SVCS. Analytical Laboratory Instrument Manufacturing.

View on SAM.govMarkdown

Response deadline

June 16, 2026 at 10:00 AM EDT

Closed 93 days ago. Posted June 2, 2026. Scheduled to archive June 17, 2026.

Description

As published on SAM.gov.

The Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH), Office of Science and Engineering Laboratories (OSEL), Division of Biomedical Physics (DBP) intends to acquire one (1) Ophthalmic Adaptive Optics (AO) Retinal Imaging System. The system will be used to support retinal imaging research, biomarker development, and regulatory science activities at the FDA White Oak Campus in Silver Spring, Maryland.

Delivery and installation shall be made to 10903 New Hampshire Avenue, Building WO62, Room G101, Silver Spring, MD 20993. For complete requirements, terms, and conditions, please refer to the attached Combined Synopsis/Solicitation (CSS) document No. RFQ-FDA-133666 .

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. June 2, 2026

    Combined synopsis and solicitation

    Due June 16, 2026 at 10:00 AM EDT. SAM.gov, notice bb0ad22260c44b928c01adfe832e942c

Points of contact

Also open from this buyer